🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

MKS Instruments shares target raisedon WFE spending outlook

EditorEmilio Ghigini
Published 06/12/2024, 06:21 AM
MKSI
-

On Wednesday, TD Cowen maintained a Buy rating on MKS Instruments (NASDAQ:MKSI) and raised the shares target to $160 from $150. The firm sees MKS Instruments as a prime beneficiary of an expected rebound in wafer fabrication equipment (WFE) spending in the coming year.

The company is particularly well-positioned to capitalize on the demand for NAND memory, which requires significant deposition and etching—a process where MKS Instruments has considerable leverage.

The analyst from TD Cowen highlighted MKS Instruments' exposure to structural advanced packaging trends, as well as to the cyclical nature of the smartphone and PC markets.

These factors contribute to the firm's positive outlook on the stock. Additionally, the recent steps taken by MKS Instruments to reduce its debt following the acquisition of Atotech, along with its convertible refinancing efforts, were seen as favorable moves that could enhance the company's financial flexibility.

According to TD Cowen, these strategic financial decisions could pave the way for MKS Instruments to achieve an earnings power of over $8 per share in the 2026 calendar year (CY26). This projection underscores the firm's confidence in the company's growth trajectory and its ability to deliver increased shareholder value in the medium term.

The raised price target reflects an optimistic view of MKS Instruments' future performance, taking into account the anticipated industry trends and the company's strategic initiatives.

The endorsement from TD Cowen suggests that MKS Instruments is well-positioned to navigate the dynamics of the semiconductor sector and emerge stronger in the following years.

In other recent news, MKS Instruments, a global provider of technologies, has been the subject of multiple financial adjustments and strategic moves. The company recently upsized and priced its private offering of convertible senior notes from $1.0 billion to $1.2 billion, due in 2030. This move is expected to generate net proceeds of approximately $1.2 billion, which MKS plans to utilize primarily to repay its outstanding Term Loan B.

Financial analysts from KeyBanc Capital Markets and Needham have responded positively to these developments. KeyBanc raised its price target for MKS Instruments from $140 to $150, maintaining an Overweight rating, while Needham increased its target from $145.00 to $153.00, keeping a Buy rating. Both firms cited the company's successful debt refinancing and favorable positioning in the semiconductor equipment sector as key reasons for their adjustments.

Furthermore, Benchmark, another financial analyst firm, has also raised its price target for MKS Instruments to $142 from $130, following the company's earnings report for the first quarter of 2024, which exceeded expectations.

These recent developments underscore MKS Instruments' strategic financial management and its commitment to reducing its leverage, which are expected to support the company's growth and operational efficiency in the coming years.

InvestingPro Insights

As MKS Instruments (NASDAQ:MKSI) garners a positive outlook from TD Cowen, real-time data and insights from InvestingPro further illuminate the investment landscape. MKSI has seen a significant uptick in analyst confidence, with 6 analysts revising their earnings upwards for the upcoming period, signaling potential growth ahead. Additionally, the stock's price has experienced notable volatility, yet it has been trading near its 52-week high, reflecting robust investor interest.

Furthermore, the company's financial health appears stable, with liquid assets surpassing short-term obligations, a reassuring sign for investors concerned about near-term liquidity. While MKSI has not been profitable over the last twelve months, analysts predict a return to profitability this year, offering a promising outlook for future earnings.

From a valuation standpoint, MKSI's market capitalization stands at $8.74 billion, and despite a negative P/E ratio for the last twelve months as of Q1 2024, the company's revenue growth remains positive at 2.7%. Moreover, MKSI has maintained its dividend payments for 14 consecutive years, with a current dividend yield of 0.68%, a testament to its commitment to returning value to shareholders.

For those looking to delve deeper into MKSI's potential, InvestingPro offers additional insights and metrics. With a coupon code PRONEWS24, investors can receive an additional 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking access to an extensive range of InvestingPro Tips. Currently, there are 8 more tips available on InvestingPro that could further guide investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.